Universidad Peruana Cayetano Heredia

Registry of people with diabetes in three Latin American countries: A suitable approach to evaluate the quality of health care provided to people with type 2 diabetes

Mostrar el registro sencillo del ítem

dc.contributor.author Commendatore, V.
dc.contributor.author Dieuzeide, G.
dc.contributor.author Faingold, C.
dc.contributor.author Fuente, G.
dc.contributor.author Luján, D.
dc.contributor.author Aschner, P.
dc.contributor.author Lapertosa, S.
dc.contributor.author Villena Chavez, Jaime Eduardo
dc.contributor.author Elgart, J.
dc.contributor.author Gagliardino, J.J.
dc.date.accessioned 2022-01-04T20:30:00Z
dc.date.available 2022-01-04T20:30:00Z
dc.date.issued 2013
dc.identifier.uri https://hdl.handle.net/20.500.12866/10512
dc.description.abstract Aims: To implement a patient registry and collect data related to the care provided to people with type 2 diabetes in six specialized centers of three Latin American countries, measure the quality of such care using a standardized form (QUALIDIAB) that collects information on different quality of care indicators, and analyze the potential of collecting this information for improving quality of care and conducting clinical research. Methods: We collected data on clinical, metabolic and therapeutic indicators, micro- and macrovascular complications, rate of use of diagnostic and therapeutic elements and hospitalization of patients with type 2 diabetes in six diabetes centers, four in Argentina and one each in Colombia and Peru. Results: We analyzed 1157 records from patients with type 2 diabetes (Argentina, 668; Colombia, 220; Peru, 269); 39 records were discarded because of data entry errors or inconsistencies. The data demonstrated frequency performance deficiencies in several procedures, including foot and ocular fundus examination and various cardiovascular screening tests. In contrast, HbA1c and cardiovascular risk factor assessments were performed with a greater frequency than recommended by international guidelines. Management of insulin therapy was sub-optimal, and deficiencies were also noted among diabetes education indicators. Conclusions: Patient registry was successfully implemented in these clinics following an interactive educational program. The data obtained provide useful information as to deficiencies in care and may be used to guide quality of care improvement efforts. en_US
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartofseries International Journal of Clinical Practice
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Humans en_US
dc.subject hypertension en_US
dc.subject major clinical study en_US
dc.subject Peru en_US
dc.subject priority journal en_US
dc.subject Argentina en_US
dc.subject angiotensin receptor antagonist en_US
dc.subject beta adrenergic receptor blocking agent en_US
dc.subject dipeptidyl carboxypeptidase inhibitor en_US
dc.subject hydroxymethylglutaryl coenzyme A reductase inhibitor en_US
dc.subject Chronic Disease en_US
dc.subject obesity en_US
dc.subject hospitalization en_US
dc.subject Hospitalization en_US
dc.subject standardization en_US
dc.subject article en_US
dc.subject Diabetes Mellitus, Type 2 en_US
dc.subject screening test en_US
dc.subject Colombia en_US
dc.subject hemoglobin A1c en_US
dc.subject insulin en_US
dc.subject non insulin dependent diabetes mellitus en_US
dc.subject oral antidiabetic agent en_US
dc.subject health care quality en_US
dc.subject calcium channel blocking agent en_US
dc.subject practice guideline en_US
dc.subject cardiovascular risk en_US
dc.subject Quality of Health Care en_US
dc.subject hyperglycemia en_US
dc.subject Registries en_US
dc.subject Delivery of Health Care en_US
dc.subject dyslipidemia en_US
dc.subject Dyslipidemias en_US
dc.subject antilipemic agent en_US
dc.subject cardiovascular procedure en_US
dc.subject Clinical Laboratory Techniques en_US
dc.subject diabetes education en_US
dc.subject disease registry en_US
dc.subject diuretic agent en_US
dc.subject eye examination en_US
dc.subject ezetimibe en_US
dc.subject fibric acid derivative en_US
dc.subject Hyperglycemia en_US
dc.subject insulin derivative en_US
dc.subject insulin treatment en_US
dc.subject metformin en_US
dc.subject Patient Education as Topic en_US
dc.subject sulfonylurea en_US
dc.title Registry of people with diabetes in three Latin American countries: A suitable approach to evaluate the quality of health care provided to people with type 2 diabetes en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1111/ijcp.12208
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00
dc.relation.issn 1742-1241


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas